Revive Therapeutics Statistics

Total Valuation

Revive Therapeutics has a market cap or net worth of CAD 4.19 million. The enterprise value is 3.91 million.

Market Cap	4.19M
Enterprise Value	3.91M

Important Dates

The next estimated earnings date is Wednesday, February 26, 2025.

Earnings Date	Feb 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Revive Therapeutics has 418.56 million shares outstanding. The number of shares has increased by 13.80% in one year.

Current Share Class	n/a
Shares Outstanding	418.56M
Shares Change (YoY)	+13.80%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	1.66%
Owned by Institutions (%)	0.01%
Float	411.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.69
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-262.88

Financial Efficiency

Return on equity (ROE) is -66.98% and return on invested capital (ROIC) is -25.29%.

Return on Equity (ROE)	-66.98%
Return on Assets (ROA)	-18.27%
Return on Capital (ROIC)	-25.29%
Revenue Per Employee	n/a
Profits Per Employee	-2.85M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -87.50% in the last 52 weeks. The beta is 0.21, so Revive Therapeutics's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-87.50%
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	45.07
Average Volume (20 Days)	274,051

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.48M
Pretax Income	-5.70M
Net Income	-5.70M
EBITDA	-3.48M
EBIT	-3.48M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	272,996
Total Debt	n/a
Net Cash	272,996
Net Cash Per Share	0.00
Equity (Book Value)	6.76M
Book Value Per Share	0.02
Working Capital	-2.68M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.27M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Revive Therapeutics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.80%
Shareholder Yield	-13.80%
Earnings Yield	-144.05%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a